Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
Clinical trial NCT06752057 · RECRUITING
Trial details
- NCT number
- NCT06752057
- Sponsor
- The First Affiliated Hospital of Nanchang University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2026-08-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.